Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1715-1716
doi: 10.1161/01.ATV.0000094360.38911.71
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, F. B.
Right arrow Articles by Stampfer, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, F. B.
Right arrow Articles by Stampfer, M. J.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1715.)
© 2003 American Heart Association, Inc.


Editorials

Is Type 2 Diabetes Mellitus a Vascular Condition?

Frank B. Hu; Meir J. Stampfer

From the Departments of Nutrition and Epidemiology, Harvard School of Public Health, Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.

Correspondence to Dr Frank Hu, Department of Nutrition, Harvard School of Public Health, 665 Huntington Ave, Boston, MA 02115. E-mail fhu@channing.harvard.edu


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Cardiovascular disease (CVD) is the most common complication of type 2 diabetes. However, CVD risk factors are elevated long before the development of diabetes,1 and the development of CVD can also precede the clinical diagnosis of type 2 diabetes.2 The close relationship between diabetes and CVD has led to the "common-soil" hypothesis,3 postulating that type 2 diabetes and CVD share common genetic and environmental antecedents, ie, "they spring from a common soil." The hypothesis implies that atherosclerosis might not be simply a consequence of diabetes but that diabetes and CVD are a single entity sharing an underlying pathophysiology.

See page 1845

Multiple lines of evidence support the common-soil hypothesis. In epidemiologic studies, the same set of diet and lifestyle factors (a diet higher in glycemic load and trans fat and lower in fiber and polyunsaturated fat, smoking, overweight and obesity, lack of regular exercise, and abstinence from alcohol) explains more than 80% of cases of coronary heart disease4 and 90% of cases of type 2 diabetes.5 Low birth weight, a marker of intrauterine nutritional deficiency, has been associated with increased risk of both diabetes and CVD in later life.6 In addition, pharmacological and lifestyle strategies to prevent type 2 diabetes have resulted in significant reductions in the occurrence of the metabolic syndrome and cardiovascular risk factors in subjects with impaired glucose tolerance,7 although it remains to be seen whether this will translate into a reduction in clinical CVD events. Furthermore, hypertension and dyslipidemia are significant predictors of type 2 diabetes, . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Kim, M. Pham, E. Maloney, N. O. Rizzo, G. J. Morton, B. E. Wisse, E. A. Kirk, A. Chait, and M. W. Schwartz
Vascular Inflammation, Insulin Resistance, and Reduced Nitric Oxide Production Precede the Onset of Peripheral Insulin Resistance
Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 1982 - 1988.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. S. Sabatine, D. A. Morrow, K. A. Jablonski, M. M. Rice, J. W. Warnica, M. J. Domanski, J. Hsia, B. J. Gersh, N. Rifai, P. M Ridker, et al.
Prognostic Significance of the Centers for Disease Control/American Heart Association High-Sensitivity C-Reactive Protein Cut Points for Cardiovascular and Other Outcomes in Patients With Stable Coronary Artery Disease
Circulation, March 27, 2007; 115(12): 1528 - 1536.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
I. Shai, M. B. Schulze, J. E. Manson, K. M. Rexrode, M. J. Stampfer, C. Mantzoros, and F. B. Hu
A Prospective Study of Soluble Tumor Necrosis Factor-{alpha} Receptor II (sTNF-RII) and Risk of Coronary Heart Disease Among Women With Type 2 Diabetes
Diabetes Care, June 1, 2005; 28(6): 1376 - 1382.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
T. Y. Wong, A. Shankar, R. Klein, B. E. K. Klein, and L. D. Hubbard
Retinal Arteriolar Narrowing, Hypertension, and Subsequent Risk of Diabetes Mellitus
Arch Intern Med, May 9, 2005; 165(9): 1060 - 1065.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Ceriello and E. Motz
Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis Revisited
Arterioscler Thromb Vasc Biol, May 1, 2004; 24(5): 816 - 823.
[Abstract] [Full Text]


Home page
DiabetesHome page
F. B. Hu, J. B. Meigs, T. Y. Li, N. Rifai, and J. E. Manson
Inflammatory Markers and Risk of Developing Type 2 Diabetes in Women
Diabetes, March 1, 2004; 53(3): 693 - 700.
[Abstract] [Full Text] [PDF]